Llwytho...
Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report
AIM OF THE STUDY: Mutant NPM1 and CEBPA have been reported in patients with acute myeloid leukaemia (AML) and intermediate cytogenetic risk, and they appear to be associated with characteristic demographic and laboratory data, as well as clinical outcome. The objective of the study was to assess the...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Termedia Publishing House
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4171470/ https://ncbi.nlm.nih.gov/pubmed/25258581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2014.43490 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|